hRPC for Retinitis Pigmentosa
(hRPCRP Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new cell therapy where special cells are injected into the eye to help people with retinitis pigmentosa, a disease that causes vision loss. The goal is to see if these cells can repair or replace damaged parts of the eye.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, you cannot participate if you have used systemic immunosuppressive agents (like corticosteroids) in the 6 months before treatment.
Who Is on the Research Team?
Jason Comander, MD
Principal Investigator
Massachusetts Eye and Ear Infirmary (MEEI)
Vince Holmes
Principal Investigator
ReNeuron Limited
Are You a Good Fit for This Trial?
Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a single subretinal injection of hRPC cells in one eye
Follow-up
Participants are monitored for safety and tolerability, with detailed ophthalmic examinations and imaging
What Are the Treatments Tested in This Trial?
Interventions
- hRPC
Find a Clinic Near You
Who Is Running the Clinical Trial?
ReNeuron Limited
Lead Sponsor